Aryl hydrocarbon receptor restrains tonic cytokine responses by inhibiting microbiota sensing in monocytes
Journal of Clinical Investigation · 01.12.2025 · 135 (23)
DOI: 10.1172/jci189937 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.10.2025. Verfasst von Adeline Cros und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institut Curie, PSL Research University, INSERM, U932, Paris, France. Hauptthemen laut MEDLINE: Receptors, Aryl Hydrocarbon, Monocytes, Cytokines, Microbiota. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIAID NIH HHS, Institut National Du Cancer.
Abstract (Originalsprache)
Immune cells are constantly exposed to microbiota-derived compounds that can engage innate recognition receptors. How this constitutive stimulation is downmodulated to avoid systemic inflammation and autoimmunity is poorly understood. Here, we show that aryl hydrocarbon receptor (AhR) deficiency in monocytes unleashed spontaneous cytokine responses in vivo, driven by stimulator of interferon genes (STING)-mediated tonic sensing of microbiota. This effect was specific to monocytes, as mice deficient for AhR specifically in macrophages did not show any dysregulation of tonic cytokine responses. AhR inhibition also increased tonic cytokine production in human monocytes. Finally, in patients with systemic juvenile idiopathic arthritis, low AhR activity in monocytes correlated with elevated cytokine responses. Our findings reveal an essential role for AhR in monocytes in restraining tonic microbiota sensing and in maintaining immune homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut Curie, PSL Research University, INSERM, U932, Paris, France.
- Institut Necker Enfants Malades - INEM, Université Paris Cité, INSERM, U1151, Paris, France.
- Baylor Institute for Immunology Research, Dallas, Texas, USA.
- Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Förderung
- NIAMS NIH HHS
- NIAID NIH HHS
- Institut National Du Cancer
- Agence Nationale de la Recherche
- National Institutes of Health
- ERC Horizon 2020-Marie Sklodowska-Curie Actions
Zitieren
APA
Cros, A., Rigamonti, A., de Juan, A., Coillard, A., Rieux-Laucat, M., Tabtim-On, D., Papillon, E., Goudot, C., Cepika, A. M., Banchereau, R., Pascual, V., Burbage, M., Becher, B., & Segura, E. (2025). Aryl hydrocarbon receptor restrains tonic cytokine responses by inhibiting microbiota sensing in monocytes. Journal of Clinical Investigation, 135(23). https://doi.org/10.1172/jci189937
Vancouver
Cros A, Rigamonti A, de Juan A, Coillard A, Rieux-Laucat M, Tabtim-On D, et al. Aryl hydrocarbon receptor restrains tonic cytokine responses by inhibiting microbiota sensing in monocytes. Journal of Clinical Investigation. 2025;135(23). doi:10.1172/jci189937
BibTeX
@article{Cros2025,
author = {Cros, Adeline and Rigamonti, Alessandra and de Juan, Alba and Coillard, Alice and Rieux-Laucat, Mathilde and Tabtim-On, Darawan and Papillon, Emeline and Goudot, Christel and Cepika, Alma-Martina and Banchereau, Romain and Pascual, Virginia and Burbage, Marianne and Becher, Burkhard and Segura, Elodie},
title = {Aryl hydrocarbon receptor restrains tonic cytokine responses by inhibiting microbiota sensing in monocytes},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {23},
doi = {10.1172/jci189937}
}
EUVIMED